Company name: Trulieve
Description: Provider of cannabis cultivation services. The company’s cannabis cultivation services include production and consumption of cannabis flowers, enabling clients to avail enhanced services.
Parent company: Trulieve Cannabis
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Acquired/Merged (Operating Subsidiary)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was acquired by Schyan Exploration for an undisclosed amount on September 21, 2018. The outstanding 10,927,500 subscription receipts of Trulieve US were exchanged for 10,927,500 subordinate voting shares of the acquirer, 3,573,450 of which were immediately converted into 35,734.50 multiple voting shares, and the 548,446 broker warrants of Trulieve US were exchanged for 548,446 broker warrants to purchase subordinate soting shares of the acquirer at an exercise price of $6.00 until September 21, 2020.
Number of active investors:
Profile last updated: 24-Sep-2018
Last known valuation:
Last known valuation date: